News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Alexion
NEWS
JOBS
IN THE PRESS
NEWS
Policy
Alexion is Under Investigation by the HHS Office of Inspector General
July 7, 2017
·
2 min read
Business
Alexion Poaches Biogen’s Longtime CFO
June 14, 2017
·
2 min read
Business
New Alexion CEO Brings Two Former Baxalta Pals and One Pfizer Alum Into the C-Suite
June 2, 2017
·
2 min read
Deals
More Alexion Turbulence Could Flush Out A Buyer
May 25, 2017
·
1 min read
Pharm Country
Alexion: A Successful Migration of a Biopharma Corporate Data Center to the Cloud
May 25, 2017
·
4 min read
Pharm Country
How Alexion is Making So Much Cash With a Drug That Treats Less Than 11,000 Patients
May 24, 2017
·
4 min read
Business
Alexion Boss Shakes Up Executive Team, Head of R&D Retires, CFO and HR Exec Step Down
May 23, 2017
·
1 min read
Policy
Brazilian Police Raid Alexion’s Office In Sales Practices Probe
May 9, 2017
·
1 min read
Pharm Country
Alexion - Among The Best Risk/Reward In Biotech?
April 28, 2017
·
1 min read
AWARDS
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Press Releases
JCR Pharmaceuticals and Alexion Achieve Milestone in Collaborative Neurodegenerative Disease Program
September 22, 2025
·
4 min read
Press Releases
JCR Pharmaceuticals Enters License Agreement with Alexion for Proprietary JUST-AAV Capsids to be Used in the Development of Genomic Medicines
July 8, 2025
·
5 min read
Press Releases
Alexion, AstraZeneca Rare Disease reaches an agreement with the pan-Canadian Pharmaceutical Alliance (pCPA) for Koselugo (selumetinib) for the treatment of paediatric patients with neurofibromatosis type 1 (NF1) who have symptomatic, inoperable plexiform neurofibromas (PN)
December 18, 2024
·
5 min read
Press Releases
KOSELUGO® (selumetinib) Showed Significant and Clinically Meaningful Improvement in Objective Response Rate Versus Placebo in Adults With Neurofibromatosis Type 1 who Have Symptomatic, Inoperable Plexiform Neurofibromas in Global Phase 3 KOMET Trial
November 12, 2024
·
14 min read
Press Releases
Monopar Announces Agreement with Alexion, AstraZeneca Rare Disease For Late-Stage Wilson Disease Drug Candidate
October 25, 2024
·
8 min read
Business
AstraZeneca demonstrates commitment to patients living with amyloidosis at the 2024 International Symposium on Amyloidosis (ISA)
May 23, 2024
·
13 min read
Business
JCR Pharmaceuticals Announces Achievement of Milestone Using J-Brain Cargo® Technology for Neurodegenerative Disease in Research Collaboration with Alexion
March 19, 2024
·
4 min read
Drug Development
Long-term ALPHA Phase III trial data showed danicopan as add-on to ULTOMIRIS® or SOLIRIS® sustained clinical improvements in subset of patients with PNH experiencing clinically significant extravascular hemolysis
December 10, 2023
·
29 min read
Business
Verge Genomics Announces Artificial Intelligence-Enabled Drug Discovery Collaboration with Alexion for Rare Neurodegenerative and Neuromuscular Diseases
September 8, 2023
·
3 min read
BioCapital
Alexion advances commitment to transform patient outcomes in rare neurological diseases at AAN 2023
March 2, 2023
·
21 min read
